The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract ...
The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...
Many RF microneedling devices are cleared by the FDA as Class II medical devices, but the agency stresses that an RF ...
The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...
D r. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...
George Tidmarsh, who resigned Sunday, is accused in a lawsuit of seeking a bribe and defaming a drug.
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
A growing number of FDA employees are eyeing the exits as chaos and uncertainty sweep through the agency, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback